{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T04:28:10Z","timestamp":1785644890684,"version":"3.56.0"},"reference-count":25,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To analyze the prevalence of preexisting palindromic rheumatism (PR) in patients with established rheumatoid arthritis (RA) and to evaluate whether these patients have a distinctive clinical and serological phenotype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Cross-sectional study in patients with established RA. Preexisting PR was determined using a structured protocol and confirmed by retrospective review of medical records. Demographic, clinical, radiological, immunological, and therapeutic features were compared in patients with and without PR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Included were 158 patients with established RA (78% female) with a mean disease duration since RA onset of 5.1 \u00b1 2.7 years. Preexisting PR was recorded in 29 patients (18%). The median time from the onset of PR to progression to RA was 1.2 years. No between-group differences in demographic features, current disease activity, radiographic erosive disease, or disability were observed. Patients with PR had a higher prevalence of smoking (72% vs 40%). Positive rheumatoid factor, anticitrullinated peptide antibodies, and anticarbamylated protein antibodies were numerically higher in patients with PR. No differences in treatment were observed except for greater hydroxychloroquine (HCQ) use in patients with PR (38% vs 6%). Palindromic flares persisted in a significant proportion of patients during the RA course, including patients in clinical remission or receiving biological disease-modifying antirheumatic drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Eighteen percent of patients with RA had a history compatible with PR previous to RA onset. No specific clinical or serological phenotype was identified in these patients, although higher HCQ use and smoking prevalence were identified. Palindromic flares may persist during the RA disease course despite treatment.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.190061","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T16:19:04Z","timestamp":1564676344000},"page":"652-657","source":"Crossref","is-referenced-by-count":15,"title":["Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?"],"prefix":"10.3899","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-4101","authenticated-orcid":false,"given":"Raul","family":"Castellanos-Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-151X","authenticated-orcid":false,"given":"Sebastian C.","family":"Rodriguez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8177-702X","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"G\u00f3mez-Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-6601","authenticated-orcid":false,"given":"Virginia","family":"Ruiz-Esquide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-3401","authenticated-orcid":false,"given":"Oscar","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-7718","authenticated-orcid":false,"given":"Julio","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-3525","authenticated-orcid":false,"given":"Andrea","family":"Cuervo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-6142","authenticated-orcid":false,"given":"Rosa","family":"Morl\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2606-0573","authenticated-orcid":false,"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-2340","authenticated-orcid":false,"given":"Isabel","family":"Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-3806","authenticated-orcid":false,"given":"Raimon","family":"Sanmarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"2020050109252810000_47.5.652.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.05.005"},{"key":"2020050109252810000_47.5.652.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120995"},{"key":"2020050109252810000_47.5.652.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.09.014"},{"key":"2020050109252810000_47.5.652.4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090025"},{"key":"2020050109252810000_47.5.652.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg268"},{"key":"2020050109252810000_47.5.652.6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2018-214175","article-title":"Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism","volume":"78","author":"Mankia","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2020050109252810000_47.5.652.7","first-page":"1240","article-title":"The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis","volume":"33","author":"Russell","year":"2006","journal-title":"J Rheumatol"},{"key":"2020050109252810000_47.5.652.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120568"},{"key":"2020050109252810000_47.5.652.9","first-page":"540","article-title":"Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism","volume":"26","author":"Gonzalez-Lopez","year":"1999","journal-title":"J Rheumatol"},{"key":"2020050109252810000_47.5.652.10","doi-asserted-by":"publisher","DOI":"10.3109\/03009741003604534"},{"key":"2020050109252810000_47.5.652.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2569-3"},{"key":"2020050109252810000_47.5.652.12","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"key":"2020050109252810000_47.5.652.13","doi-asserted-by":"crossref","first-page":"e0161141","DOI":"10.1371\/journal.pone.0161141","article-title":"Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies","volume":"11","author":"Montes","year":"2016","journal-title":"PLoS One"},{"key":"2020050109252810000_47.5.652.14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.reuma.2015.08.002","article-title":"Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study","volume":"12","author":"Corominas","year":"2016","journal-title":"Reumatol Clin"},{"issue":"Suppl 10","key":"2020050109252810000_47.5.652.15","first-page":"2465","article-title":"Characterizing palindromic symptoms in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort Study","volume":"70","author":"Ellingwood","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020050109252810000_47.5.652.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131545"},{"key":"2020050109252810000_47.5.652.17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)","volume":"73","author":"Dougados","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020050109252810000_47.5.652.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110410"},{"key":"2020050109252810000_47.5.652.19","doi-asserted-by":"publisher","DOI":"10.1186\/ar4498"},{"key":"2020050109252810000_47.5.652.20","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/annrheumdis-2012-202254","article-title":"Smoking and overweight determine the likelihood of developing rheumatoid arthritis","volume":"72","author":"de Hair","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2020050109252810000_47.5.652.21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13075-017-1329-6","article-title":"Differing specificities and isotypes of anti-citrullinated peptide\/protein antibodies in palindromic rheumatism and rheumatoid arthritis","volume":"19","author":"Cabrera-Villalba","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 10","key":"2020050109252810000_47.5.652.22","first-page":"480","article-title":"ANTI-carbamylated protein antibodies (CARP) in palindromic rheumatism: prevalence and clinical significance","volume":"69","author":"Castellanos-Moreira","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020050109252810000_47.5.652.23","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.22755","article-title":"An unexpectedly high frequency of MEFV mutations in patients with anti\u2013citrullinated protein antibody\u2013negative palindromic rheumatism","volume":"56","author":"Ca\u00f1ete","year":"2007","journal-title":"Arthritis Rheumatol"},{"key":"2020050109252810000_47.5.652.24","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000550"},{"key":"2020050109252810000_47.5.652.25","first-page":"41","article-title":"Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials","volume":"27","author":"Gonzalez-Lopez","year":"2000","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T16:26:59Z","timestamp":1588350419000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5,1]]}},"alternative-id":["10.3899\/jrheum.190061"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190061","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}